Scinai Immunotherapeutics (SCNI) Interest Expenses (2014 - 2022)

Scinai Immunotherapeutics has disclosed Interest Expenses across 9 years of filings, most recently posting $2.6 million for Q3 2022.

• Interest Expenses for Q3 2022 came in at $2.6 million, up 191.22% year-over-year; the trailing twelve-month figure through Jun 2023 was $2.6 million (up 125.8% YoY), and the FY2021 annual result was -$10.9 million, up 30.5% from the prior year.
• Interest Expenses came in at $2.6 million for Q3 2022 at Scinai Immunotherapeutics, up from -$3.6 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $2.6 million in Q3 2022 to a low of -$3.6 million in Q2 2022.
• The 5-year median for Interest Expenses is -$755000.0 (2020), against an average of -$1.2 million.
• Across the five-year window, Interest Expenses slumped 2147.43% in 2019 and jumped 191.22% in 2022, its largest moves.
• Scinai Immunotherapeutics' Interest Expenses stood at -$460000.0 in 2018, then slumped by 30.65% to -$601000.0 in 2019, then declined by 28.62% to -$773000.0 in 2020, then tumbled by 252.26% to -$2.7 million in 2021, then soared by 193.83% to $2.6 million in 2022.
• The last three Interest Expenses figures came in at $2.6 million (Q3 2022), -$3.6 million (Q2 2022), and -$737000.0 (Q1 2022), per Business Quant data.